Summit Partners Public Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trade Desk
TTD
|
+$51.4M |
| 2 |
GeneDx Holdings
WGS
|
+$38.8M |
| 3 |
BridgeBio Pharma
BBIO
|
+$38.1M |
| 4 |
WAY
Waystar Holding Corp
WAY
|
+$34.7M |
| 5 |
Allegro MicroSystems
ALGM
|
+$34.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$96.1M |
| 2 |
Reddit
RDDT
|
+$87.4M |
| 3 |
Astera Labs
ALAB
|
+$60.8M |
| 4 |
Marvell Technology
MRVL
|
+$57.5M |
| 5 |
Tower Semiconductor
TSEM
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.55% |
| 2 | Technology | 15.11% |
| 3 | Industrials | 6.16% |
| 4 | Communication Services | 5.74% |
| 5 | Consumer Discretionary | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CALL
Teradata
TDC
$2.55B
| – | – |
-90,000
| Closed | -$2.8M |
|
202
CALL
Uber
UBER
$153B
| – | – |
-200,000
| Closed | -$12.1M |
|
203
Vicor
VICR
$10.2B
| – | – |
-368,100
| Closed | -$17.8M |
|
|
VRNA
204
CALL
DELISTED
Verona Pharma
VRNA
| – | – |
-400,000
| Closed | -$18.6M |
|
205
Vistra
VST
$47.4B
| – | – |
-134,921
| Closed | -$18.6M |
|
|
206
PUT
Vistra
VST
$47.4B
| – | – |
-130,000
| Closed | -$17.9M |
|
207
CALL
WIX.com
WIX
$2.52B
| – | – |
-30,000
| Closed | -$6.44M |
|
|
208
WIX.com
WIX
$2.52B
| – | – |
-10,000
| Closed | -$2.15M |
|
|
209
PUT
Astera Labs
ALAB
$58B
| – | – |
-1,149,300
| Closed | -$152M |
|
210
PUT
GE Vernova
GEV
$264B
| – | – |
-100,000
| Closed | -$32.9M |
|
|
OKLO
211
PUT
Oklo
OKLO
$8.42B
| – | – |
-1,000,000
| Closed | -$21.2M |
|
|
WAY
212
CALL
Waystar Holding Corp
WAY
$4.65B
| – | – |
-260,000
| Closed | -$9.54M |
|
Similar funds
Summit Partners Public Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Summit Partners Public Asset Management held 212 positions worth $3.89B, down 26% from $5.24B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Summit Partners Public Asset Management withdrew a net $899M in Q1 2025, closing 70 positions and reducing 51 holdings. Its most notable exit was Marvell Technology, an estimated $57.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.
Against the trend, Summit Partners Public Asset Management opened a new position in BridgeBio Pharma worth $39M.
- Summit Partners Public Asset Management's largest Q1 2025 buy was BridgeBio Pharma: 1,129,592 shares worth $39M.
- Summit Partners Public Asset Management added most to Trade Desk in Q1 2025, an estimated $51.4M increase.
- Summit Partners Public Asset Management's biggest Q1 2025 reduction was TSMC, cutting an estimated $96.1M.
- Summit Partners Public Asset Management fully exited Marvell Technology in Q1 2025, selling an estimated $57.5M.
- Summit Partners Public Asset Management's ten largest holdings make up 25% of its $3.89B portfolio in Q1 2025.
- Summit Partners Public Asset Management opened 64 new positions and closed 70 in Q1 2025.
- Summit Partners Public Asset Management's portfolio value fell 26% quarter-over-quarter to $3.89B.
Based on Summit Partners Public Asset Management's 13F filing for Q1 2025, filed 15 May 2025.